http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111939269-B

Outgoing Links

Predicate Object
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B2200-11
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02P20-55
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-0039
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K41-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F15-0093
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-0052
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-517
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-545
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6901
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D409-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-555
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-0097
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F15-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-555
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K49-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-69
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D409-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-517
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D405-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K41-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-52
filingDate 2020-07-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2022-11-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2022-11-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-111939269-B
titleOfInvention Magnetic targeting cell membrane modification ligand, drug-loading material, preparation method and application thereof
abstract The invention discloses a class of magnetic-targeting cell membrane modifying ligands, drug-loaded materials and their preparation methods and applications. The magnetic-targeting cell membrane modifying ligands have general structural formulas such as series I or series II in formula (1). shown. In the present invention, the magnetic targeting cell membrane drug-loading material is obtained by chemically covalently modifying the cell membrane with a magnetically targeting cell membrane modifying ligand. In vitro tests show that this type of material has good stability, can be effectively taken up by tumor cells, and is effective against tumor cells. It has high selectivity, and at the same time, this type of material has significant paramagnetism, and can achieve magnetic targeting effect under the condition of external magnetic field. In the in vitro anti-tumor test, this kind of drug-loaded material has significant anti-tumor activity and almost no toxicity to normal cells, indicating that it has the potential use of targeted therapy for malignant tumors.
priorityDate 2020-07-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID46906042
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449982031
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5281426
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID409687105
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID20339034
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID239041
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21885813
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID19732
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID455502157
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID413807576
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID323
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID69023
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID573621
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1032
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419589066
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID208908
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448387263
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2733207
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID424499253
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419556509
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID416017452
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419525871
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID87293
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419491185
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419492306
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID864
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419566024
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14789
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414886086
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452327997
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456438065
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426125495
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448543596
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6951563
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419481434
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23925

Total number of triples: 70.